Advancements in Immunotherapy for Melanoma Skin Cancer
Researchers studying immunotherapy drugs have made progress that may soon lead to improved treatments for people with advanced melanoma.
FDA Approves 2 New Melanoma Drugs
The US Food and Drug Administration (FDA) has approved 2 new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), to treat melanoma that has spread or that can’t be surgically removed.
The FDA Proposes Warning Labels for Tanning Beds
The US Food and Drug Administration (FDA) has issued a proposal to reclassify tanning beds and sunlamps and require warning labels advising young people not to use them.
Aspirin Linked to Lower Melanoma Risk in Study
A study of women ages 50 to 79 has found that taking aspirin is associated with a lower risk of melanoma skin cancer.
Cancer Can Be Treated During Pregnancy
When a pregnant woman is diagnosed with cancer, her treatment decisions are complicated by concern about how treatment may affect the baby’s health.
Rates of Melanoma Deaths Differ by Education
A new study from the American Cancer Society found that declines in deaths from melanoma, a kind of skin cancer, are limited to those with the most education.
Annual Report: More Than a Million Cancer Deaths Avoided in 2 Decades
Newly published statistics from the American Cancer Society show that cancer death rates in the U.S. continue to decrease.
FDA Approves Zelboraf for Melanoma
The US Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for some people with advanced melanoma.
Bang! Zap! Pow!
The newest graphic novel in a series designed to explain cancer to children depicts superhero medical experts and cartoon cancer cells.
Ipilimumab Approved for Melanoma
The FDA has approved the drug ipilimumab for advanced melanoma, the most serious form of skin cancer.
Experimental Drugs Show Promise Against Melanoma
Results from two new studies are raising hopes of progress against metastatic melanoma.
Study Links Tanning Bed Use to Increased Risk of Melanoma
People who use tanning beds are more likely to develop melanoma, the deadliest form of skin cancer, than never users, according to a new study